Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
44
Number of overlapping holdings
20.0%
% of IBBQ's 220 holdings also in WDNA
52.4%
% of WDNA's 90 holdings also in IBBQ
Overlap by Weight
Sector Drift (IBBQ minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 8.1% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 8.5% | 1.8% | 1.8% |
|
AMGEN INC | 8.2% | 1.7% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% | 1.6% | 1.6% |
|
UNITED THERAPEUTICS CORP | 1.4% | 1.7% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
IBBQ Overweight Relative to WDNA
|
VERTEX PHARMACEUTICALS INC | 6.7% |
|
AMGEN INC | 6.6% |
|
GILEAD SCIENCES INC | 6.2% |
|
REGENERON PHARMACEUTICALS | 5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.1% |
|
ALNYLAM PHARMACEUTICALS INC | 2.0% |
 |
SANOFI-AVENTIS-ADR | 1.7% |
|
SUMMIT THERAPEUTICS INC | 1.5% |
|
INSMED INC | 1.5% |
|
INTRA-CELLULAR THERAPIES INC | 1.4% |
IBBQ Underweight Relative to WDNA
|
NATERA INC | -3.7% |
|
TWIST BIOSCIENCE CORP. | -3.0% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
ELI LILLY & CO | -2.7% |
|
VERICEL CORPORATION | -2.3% |
|
BLUEPRINT MEDICINES CORP. | -2.0% |
|
VERACYTE INC | -1.8% |
|
AGIOS PHARMACEUTICALS INC | -1.7% |
|
BRIDGEBIO PHARMA, INC. | -1.7% |
 |
NOVARTIS AG | -1.7% |